Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Hart, Robert G., Pearce, Lesly A., Aguilar, Maria I.·2007·Annals of Internal Medicine

DOI 10.7326/0003-4819-146-12-200706190-00007

Cited by (1,005)

Items 901–1,000 of 1,005

Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome
Jong‐Moo Park, Kyusik Kang, Yong‐Jin Cho, Keun‐Sik Hong, Kyung Bok Lee, Tai Hwan Park, Soo Joo Lee, Youngchai Ko, Moon‐Ku Han, Jun Lee et al. · 2016 · Annals of Neurology
Burden of disease from atrial fibrillation in adults from seven countries in Latin America
LuzAngela Cubillos, Alexandra Haddad, J.F. Mould, Andreas Kuznik · 2014 · International Journal of General Medicine
No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke
Ferdinand Oliver Bohmann, Ana Mirceska, Josef M. Pfeilschifter, Edelgard Lindhoff‐Last, Helmuth Steinmetz, Christian Foerch, Waltraud Pfeilschifter · 2012 · PLoS ONE
Mixed Treatment Comparison Meta-Analysis of Aspirin, Warfarin, and New Anticoagulants for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
Abdullah Mufareh Assiri, Omar Al-Majzoub, Abir O. Kanaan, Jennifer L. Donovan, Matthew J. Silva · 2013 · Clinical Therapeutics
Cerebral Microbleeds and Macrobleeds: Should They Influence Our Recommendations for Antithrombotic Therapies?
Kellen E. Haley, Steven Mark Greenberg, M. Edip Gurol · 2013 · Current Cardiology Reports
Underuse of anticoagulation in patients with atrial fibrillation
Ajay Vallakati, William R. Lewis · 2015 · Postgraduate Medicine
Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation
Min Jun, Matthew Thomas James, Zhihai Ma, Jianguo Zhang, Marcello A. Tonelli, Finlay Aleck McAlister, Braden Manns, Pietro Ravani, Robert Ross Quinn, Natasha Wiebe et al. · 2016 · American Journal of Kidney Diseases
Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation
Michał Mazurek, Eduard Shantsila, Deirdre A. Lane, A. Wolff, Marco Proietti, Gregory Y.H. Lip · 2017 · Mayo Clinic Proceedings
Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines
William F. McIntyre, Jeff S. Healey · 2017 · Journal of Atrial Fibrillation
Ethical Challenges With Smartwatch-Based Screening for Atrial Fibrillation: Putting Users at Risk for Marketing Purposes?
Christopher Predel, Florian Steger · 2021 · Frontiers in Cardiovascular Medicine
Automatic Mobile Health Arrhythmia Monitoring for the Detection of Atrial Fibrillation: Prospective Feasibility, Accuracy, and User Experience Study
Onni E. Santala, Jari Halonen, Susanna Martikainen, Helena Jäntti, Tuomas T. Rissanen, Mika P. Tarvainen, Tomi P Laitinen, Tiina M. Laitinen, Eemu‐Samuli Väliaho, Juha E.K. Hartikainen et al. · 2021 · JMIR mhealth and uhealth
Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms
Steven A. Lubitz, Owen Parsons, Christopher D. Anderson, Emelia J. Benjamin, Rainer Malik, Lu-Chen C Weng, Martin Dichgans, Cathie L. M. Sudlow, Peter Malcolm Rothwell, Jonathan M. Rosand et al. · 2017 · Stroke
Underuse of anticoagulation in stroke patients with atrial fibrillation – the FibStroke Study
Antti Palomäki, Pirjo E. Mustonen, Juha E.K. Hartikainen, Ilpo O. Nuotio, Tuomas Kiviniemi, Antti Ylitalo, Päivi H. Hartikainen, Juhani K.E. Airaksinen · 2015 · European Journal of Neurology
Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation
Cheuk‐Man Yu, Ahmed A. Khattab, Stefan Christian Bertog, Alex Pui‐Wai Lee, Joey SW Kwong, Horst Sievert, Bernhard Meier · 2013 · Nature Reviews Cardiology
Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation
Vanessa Roldán, Ana B. Arroyo, Salam Salloum‐Asfar, Sergio Manzano‐Fernández, Nuria García‐Barberá, Francisco R. Marín, Vicente Vicente, Rocío Gónzález‐Conejero, Constantino Martı́nez · 2014 · Thrombosis and Haemostasis
Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA 2 DS 2 -VASc Score 1 in Men, 2 in Women) Be Anticoagulated?
Gregory Y.H. Lip, Peter Brønnum Nielsen · 2016 · Circulation
High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease
Cian P. McCarthy, Omair Khwaja Yousuf, Álvaro Alonso, Elizabeth Selvin, Hugh G Calkins, John William McEvoy · 2017 · The American Journal of Cardiology
Updates on Prevention of Cardioembolic Strokes
Mehmet Akif Topçuoğlu, Liping Liu, Dong‐Eog Kim, M. Edip Gurol · 2018 · Journal of Stroke
Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population
Kiran B. Gupta, Jeffrey N. Trocio, Allison V. Keshishian, Qisu Zhang, Oluwaseyi Dina, Jack Mardekian, Lisa C. Rosenblatt, Xianchen Liu, Shalini Hede, Anagha Nadkarni et al. · 2018 · Journal of Managed Care & Specialty Pharmacy
Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants
Alice Morgan, Grace Joshy, Andrea L. Schaffer, Tracey‐Lea Laba, Melisa J. Litchfield, Sallie‐Anne Pearson, Emily Banks · 2018 · PLoS ONE
Wrist band photoplethysmography in detection of individual pulses in atrial fibrillation and algorithm-based detection of atrial fibrillation
Eemu‐Samuli Väliaho, Pekka Kuoppa, Jukka A. Lipponen, Tero J. Martikainen, Helena Jäntti, Tuomas T. Rissanen, Indrek Kolk, Maaret Kaarina Castrén, Jari Halonen, Mika P. Tarvainen et al. · 2019 · EP Europace
Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?
Jeff S. Healey, Guy Amit, Thalia Shoshana Field · 2019 · Current Opinion in Neurology
Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant Use in a National Cohort of Older Americans
Anna L. Parks, S. Y. Jeon, W. J. Boscardin, Michael A. Steinman, Alexander K. Smith, Margaret C. Fang, Sachin J. Shah · 2020 · medRxiv
Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018
Stine Munk Hald, Sören Möller, Luis Alberto García Rodríguez, Rustam Al‐Shahi Salman, Mike Sharma, Hanne Christensen, Maja Hellfritzsch, Anton Pottegård, Jesper Hallas, David Gaist · 2021 · JAMA Network Open
Vitamin K Antagonists and Risk of Subdural Hematoma
Ben J. Connolly, Lesly A. Pearce, Robert G. Hart · 2014 · Stroke
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
Alpesh Amin · 2013 · Clinical Interventions in Aging
New Anticoagulants for Atrial Fibrillation
Magdalena Sobieraj‐Teague, Martin James O'Donnell, John W. Eikelboom · 2009 · Seminars in Thrombosis and Hemostasis
Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta‐analysis
M. Melkonian, Witold Jarzebowski, É. Pautas, V. Siguret, J. Belmin, C. Lafuente-Lafuente · 2017 · Journal of Thrombosis and Haemostasis
The effectiveness and safety of fixed low‐dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin (CME)
Cindy Varga, Sultan Altouri, Stella Papadoukakis, Stephen N. Caplan, Susan Rebecca Kahn, Mark D. Blostein · 2012 · Transfusion
Meta-analysis of Efficacy and Safety of the New Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation
Bin Jia, Henry Lynn, Fen Rong, Wei Zhang · 2014 · Journal of Cardiovascular Pharmacology
Prevalence of auricular thrombosis before atrial flutter cardioversion: a 17-year transoesophageal echocardiographic study
Alberto Cresti, Miguel Ángel García Fernández, Francesco De Sensi, Gennaro Miracapillo, Andréa Picchi, Marco Scalese, Silva Severi · 2015 · EP Europace
Catheter Ablation for Atrial Fibrillation
Stuart P. Thomas, Prashanthan Sanders · 2012 · Heart Lung and Circulation
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy
Craig Ian Coleman, Sylvia K. Haas, Alexander G.G. Turpie, Silvia Kuhls, Susanne Hess, Thomas Evers, Pierre Amarenco, Paulus F. Kirchhof, A. John Camm, on behalf of the XANTUS Investigators · 2016 · Clinical Cardiology
Treatment Changes among Users of Non‐Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Maja Hellfritzsch, Steen Husted, Erik Lerkevang Grove, Lotte Rasmussen, Birgitte Klindt Poulsen, Søren Paaske Johnsen, Jesper Hallas, Anton Pottegård · 2016 · Basic & Clinical Pharmacology & Toxicology
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training
Gavino Casu, Michele Massimo Gulizia, Giulio Molon, Patrizio Mazzone, Andrea Audo, Giancarlo Casolo, Emilio Di Lorenzo, Michele Portoghese, Christian Pristipino, Renato Pietro Ricci et al. · 2017 · European Heart Journal Supplements
Prediction Score for Anticoagulation Control Quality Among Older Adults
Kueiyu Joshua Lin, Daniel E. Singer, Robert J. Glynn, Suzanne V. Blackley, Li Zhou, Jun Liu, Gina Dube, Lynn B. Oertel, Sebastian Schneeweiß · 2017 · Journal of the American Heart Association
Prevalence of Non-valvular Atrial Fibrillation Based on Geographical Distribution and Socioeconomic Status in the Entire Korean Population
So‐Ryoung Lee, Eue‐Keun Choi, Kyungdo Han, Myung‐Jin Cha, Seil Oh · 2018 · Korean Circulation Journal
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation
Zhengbiao Xue, Hao Zhang · 2019 · Stroke
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists
Marc Sorigué, Miloš D. Miljković · 2019 · Journal of Oncology Practice
Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial
Apostolos Tzikas, Athanasios Samaras, Αναστάσιος Κάρτας, Dimitra Vasdeki, George Fotos, George Dividis, Eleni Paschou, Evropi Forozidou, Paraskevi Tsoukra, E Kotsi et al. · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
Patterns of Infarction on MRI in Patients With Acute Ischemic Stroke and Cardio-Embolism: A Systematic Review and Meta-Analysis
Angelos Sharobeam, Leonid P. Churilov, Mark William Parsons, Geoffrey Alan Donnan, Stephen M. Davis, Bernard Yan · 2020 · Frontiers in Neurology
Exploring stroke risk and prevention in China: insights from an outlier
Xinrou Lin, Hongxuan Wang, Xiaoming Rong, Ruxun Huang, Ying Peng · 2021 · Aging
Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia
Robert Ploen, Markus Zorn, Li Sun, Wei Zhou, Roland C. Veltkamp · 2013 · Thrombosis and Haemostasis
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation
Jonathan Paul Piccini, Renato D. Lópes, Kenneth W. Mahaffey · 2010 · Current Opinion in Cardiology
Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
Ilaria Cavallari · 2018 · The Anatolian Journal of Cardiology
2025 Clinical practice guidelines for Atrial fibrillation and flutter
Elena Zelikovna Golukhova, Golitsyn Sp, Е. Н. Михайлов, A.S.h. Revishvili, Mari G. Arakelyan, E. Yu. Vasilyeva, Karapet V. Davtyan, Oksana M. Drapkina, L. Yu. Drozdova, Кропачева Екатерина Станиславовна et al. · 2026 · Russian Journal of Cardiology
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Winnie W. Nelson, Sunita M Desai, ChandrasekharRao Venkata Damaraju, Lang Lu, Larry E. Fields, Peter Wildgoose, Jeffery R. Schein · 2015 · American Journal of Cardiovascular Drugs
Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico
Blanca Fuentes, J. Gállego, Antonio Gil-Núñez, Ana Morales, Francisco F. Purroy, Jaume Roquer, Tomás Segura, Javier Tejada, Aida Pilar Lago, Exuperio Díez‐Tejedor et al. · 2011 · Neurología
Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications
Vivencio Barrios, Carlos Escobar · 2013 · Expert Review of Cardiovascular Therapy
Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong
Jason C. S. Ho, Andy M. Chang, Bryan P. Yan, Cheuk‐Man Yu, Yat Yin Lam, Vivian Wing Yan Lee · 2012 · Clinical Cardiology
New Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
PRAKASH C. DEEDWANIA · 2013 · The American Journal of Medicine
Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome
Kai Halbritter, Jan Beyer‐Westendorf, Jörg Nowotny, Sven Pannach, Eberhard Kuhlisch, Sebastian Schellong · 2013 · Journal of Thrombosis and Haemostasis
Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Niamh Hannon, Elizabeth L. Callaly, Alan R. Moore, Danielle Ní Chróinín, Orla C. Sheehan, Michael Marnane, Áine Merwick, Lorraine Kyne, Joseph Duggan, Patricia M. E. McCormack et al. · 2011 · Stroke
From decision to shared-decision: Introducing patients’ preferences into clinical decision analysis
Lucia Sacchi, Stefania Rubrichi, Carla Rognoni, Silvia Panzarasa, Enea Parimbelli, Andrea Mazzanti, Carlo Napolitano, Silvia Giuliana Priori, Silvana Quaglini · 2014 · Artificial Intelligence in Medicine
Does the STAF score help detect paroxysmal atrial fibrillation in acute stroke patients?
Solveig Horstmann, Timolaos Rizos, Janina Güntner, Andreas Hug, Ekkehart Jenetzky, Ulrike Krumsdorf, Roland C. Veltkamp · 2012 · European Journal of Neurology
Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study)
Celina Mei Yong, Farnaz Azarbal, Freddy Abnousi, Paul A. Heidenreich, Susan K. Schmitt, Jun Fan, Claire T. Than, Aditya J. Ullal, Felix Yang, Ciaran S. Phibbs et al. · 2015 · The American Journal of Cardiology
Improvement in use of anticoagulation therapy in patients with ischemic stroke: Results from Get With The Guidelines–Stroke
William R. Lewis, Gregg C. Fonarow, Maria V. Grau‐Sepulveda, Eric Edward Smith, Deepak L. Bhatt, Adrian F. Hernandez, DaiWai M. Olson, Eric David Peterson, Lee H. Schwamm · 2011 · American Heart Journal
Management of atrial fibrillation in chronic kidney disease: Double trouble
Camus Nimmo, Matthew James Wright, David J.A. Goldsmith · 2013 · American Heart Journal
SCAI/ACC/HRS Institutional and Operator Requirements for Left Atrial Appendage Occlusion
Clifford J. Kavinsky, Fred M Kusumoto, Anthony A. Bavry, Steven R. Bailey, Kenneth A. Ellenbogen, Paul L. Hess, Daniel Lawrence Lustgarten, Issam D. Moussa, Christian Spies · 2015 · Journal of the American College of Cardiology
Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation
Gregory Y.H. Lip, Deirdre A. Lane · 2013 · Circulation Journal
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score
Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y.H. Lip · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: the atrial fibrillation detect study
Giuseppe Ciconte, Massimo Saviano, Luigi Giannelli, Žarko Ćalović, Mario Baldi, Cristiano Ciaccio, Amarild Cuko, Raffaele Vitale, Daniele Giacopelli, Manuel Antonio Conti et al. · 2016 · EP Europace
Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk
M. Edip Gurol · 2017 · Stroke
Atrial fibrillation in patients with inherited cardiomyopathies
Cynthia Yeung, Andres A. Enriquez, Laiden Suarez‐Fuster, Adrian M Baranchuk · 2018 · EP Europace
GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study
Frederik Dalgaard, Karen S. Pieper, Freek W.A. Verheugt, A. John Camm, Keith A.A. Fox, Ajay K. Kakkar, Jannik Langtved Pallisgaard, Peter Vibe Rasmussen, Henk C P M van Weert, Tommi Bo Lindhardt et al. · 2019 · BMJ Open
Cryptogenic stroke and atrial fibrillation in a real-world population: the role of insertable cardiac monitors
Maria Vittoria De Angelis, Vincenzo Di Stefano, Raffaella Franciotti, Nanda Furia, Enrico Di Girolamo, MARCO C. ONOFRJ, Massimiliano Faustino · 2020 · Scientific Reports
Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening
Jessica Joan Orchard, Jialin Li, Ben Freedman, Ruth J Webster, Glenn P. Salkeld, Charlotte Mary Hespe, Robyn D Gallagher, Anushka A Patel, Bishoy Kamel, Lis Neubeck et al. · 2020 · Journal of the American Heart Association
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants
David Julian Seiffge, Duncan Wilson, Gareth Ambler, Gargi Banerjee, Isabel Charlotte Hostettler, Henry Houlden, Clare Shakeshaft, Hannah Cohen, Tarek Ahmed Yousry, Rustam Al‐Shahi Salman et al. · 2021 · Journal of Neurology Neurosurgery & Psychiatry
Ischaemic stroke in anticoagulated patients with atrial fibrillation
Christoph Stretz, Teddy Y. Wu, Duncan Wilson, David Julian Seiffge, Eric Edward Smith, M. Edip Gurol, Shadi R. Yaghi · 2021 · Journal of Neurology Neurosurgery & Psychiatry
Novel oral anticoagulants in non-valvular atrial fibrillation
Tatjana Potpara, Gregory Y.H. Lip · 2013 · Best Practice & Research Clinical Haematology
New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome
Estella M. Davis, Kathleen A. Packard, Jon T. Knezevich, Jennifer Annette Campbell · 2011 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP II
Katrin Kemp Gudmundsdottir, Emma Svennberg, Leif Friberg, Tove Hygrell, Viveka Frykman, Faris Al‐Khalili, Ziad Hijazi, Mårten Rosenqvist, Johan Engdahl · 2024 · Circulation
Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
Charalampos Kasmeridis, Stavros Z. Apostolakis, Lars Holger Ehlers, Lars Hvilsted Rasmussen, Giuseppe Boriani, Gregory Y.H. Lip · 2013 · PharmacoEconomics
Aspirin Therapy and Risk of Subdural Hematoma: Meta-analysis of Randomized Clinical Trials
Ben J. Connolly, Lesly A. Pearce, Tobias Kurth, Carlos S. Kase, Robert G. Hart · 2013 · Journal of Stroke and Cerebrovascular Diseases
International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation
Jorge Suárez, Jonathan Paul Piccini, Li Liang, John James Atherton, Chris Hayward, Henry Krum, Gregg C. Fonarow, Renato D. Lópes, Adrian F. Hernandez · 2012 · American Heart Journal
Apixaban: an Oral Direct Factor-Xa Inhibitor
David Jiménez, Roger D. Yusen, Eduardo Ramacciotti · 2012 · Advances in Therapy
Temporal Trends in Ischemic Stroke and Anticoagulation Therapy Among Medicare Patients With Atrial Fibrillation
Gautam R. Shroff, Craig A. Solid, Charles A. Herzog · 2012 · JAMA Internal Medicine
Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in Belgium
Hanne Wouters, Vincent Thijs, Lieven Annemans · 2013 · Journal of Medical Economics
Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin
Sarag Burgess, Natalie Crown, Martha Louzada, George K. Dresser, Richard B. Kim, Alejandro Lazo‐Langner · 2013 · Journal of Thrombosis and Haemostasis
Predictive Value of the CHA2DS2-VASc Score in Atrial Fibrillation Patients at High Risk for Stroke Despite Oral Anticoagulation
Eva Jover, Vanessa Roldán, Pilar Gallego, Diana Hernández‐Romero, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip, Francisco R. Marín · 2012 · Revista Española de Cardiología (English Edition)
Natriuretic peptides for the detection of paroxysmal atrial fibrillation
Joachim Seegers, Markus Zabel, Timo Grüter, Antje Ammermann, Mark Weber-Krüger, Frank Edelmann, Götz Gelbrich, Lutz Binder, Christoph Herrmann‐Lingen, Klaus Gröschel et al. · 2015 · Open Heart
Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation
Wengen Zhu, Linghua Fu, Ying Ding, Lin Huang, Zhenyan Xu, Jinzhu Hu, Kui Hong · 2016 · International Journal of Cardiology
Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
Simone Y. Loo, Janie Coulombe, Sophie Dell’Aniello, James M. Brophy, Samy Suissa, Christel Renoux · 2018 · BMJ Open
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
Wesley T. O’Neal, Pratik B. Sandesara, J’Neka S. Claxton, Richard F. MacLehose, Lin Y. Chen, Lindsay G.S. Bengtson, Alanna M. Chamberlain, Faye L. Norby, Pamela L. Lutsey, Álvaro Alonso · 2018 · Journal of the American Heart Association
Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation
Anna Gundlund, Ying Xian, Eric David Peterson, Jawad H. Butt, Kasper Gadsbøll, Jonas Bjerring Olesen, Lars Køber, Christian Tobias Torp-Pedersen, Gunnar Gislason, Emil Loldrup Fosbøl · 2018 · JAMA Network Open
Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry
Ignacio Cruz‐González, Rocío González-Ferreiro, Xavier Freixa, Sameer A. Gafoor, Samera Shakir, Heyder Omran, Sérgio Luis Berti, Gennaro Santoro, Joëlle Kefer, Ulf Landmesser et al. · 2019 · Revista Española de Cardiología (English Edition)
Identification of Markers Associated With Development of Stroke in “Clinically Low‐Risk” Atrial Fibrillation Patients
Seung Yong Shin, Sang Jin Han, Jin Seok Kim, Sung Il Im, Jaemin Shim, Jinhee Ahn, Eun Mi Lee, Yae Min Park, Jun Hyung Kim, Gregory Y.H. Lip et al. · 2019 · Journal of the American Heart Association
Uptake of a primary care atrial fibrillation screening program (AF-SMART): a realist evaluation of implementation in metropolitan and rural general practice
Jessica Joan Orchard, Jialin Li, Robyn D Gallagher, Ben Freedman, Nicole Lowres, Lis Neubeck · 2019 · BMC Family Practice
10-Year Trends of Antithrombotic Therapy Status and Outcomes in Japanese Atrial Fibrillation Patients ― The Fushimi AF Registry ―
Masaharu Akao, Hisashi Ogawa, Nobutoyo Masunaga, Kimihito Minami, Kenjiro Ishigami, Syuhei Ikeda, Kosuke Doi, Yasuhiro Hamatani, Takashi Yoshizawa, Yuya Ide et al. · 2022 · Circulation Journal
Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials
Aaron Liew, Martin James O'Donnell, James Demetrios Douketis · 2014 · Journal of Thrombosis and Haemostasis
Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation
Pak‐Hei Chan, Duo Huang, Jo Jo Hai, Wenhua Li, Lixue Yin, Esther W. Chan, Ian Chi Kei Wong, Chu‐Pak Lau, Chern‐En Chiang, Jun Zhu et al. · 2015 · Heart Rhythm
Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Focus on Apixaban
Tatjana Potpara, Marija M. Polovina, Marina M. Licina, Radan Stojanović, Milica S. Prostran, Gregory Y.H. Lip · 2012 · Advances in Therapy
The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score
Gregory Y.H. Lip, Peter Brønnum Nielsen, Flemming Skjøth, Deirdre A. Lane, Lars Hvilsted Rasmussen, Torben Bjerregaard Larsen · 2014 · CHEST Journal
How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation?
Stephan Rietbrock, Jonathan M. Plumb, Arlene M. Gallagher, Tjeerd Pieter van Staa · 2009 · Thrombosis and Haemostasis
Antithrombotic Therapy Use at Discharge and 1 Year in Patients With Atrial Fibrillation and Acute Stroke
Renato D. Lópes, Bimal R. Shah, DaiWai M. Olson, Xin Zhao, Wenqin Pan, Cheryl Bushnell, Eric David Peterson · 2011 · Stroke
Concerns About the Use of New Oral Anticoagulants for Stroke Prevention in Elderly Patients with Atrial Fibrillation
Claudia Stöllberger, Josef Finsterer · 2013 · Drugs & Aging
Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study
Alex M. Cressman, Erin M. Macdonald, Zhan Yao, Peter C. Austin, Tara Gomes, John Michael Paterson, Moira K. Kapral, Muhammad Mamdani, David Nelson Juurlink · 2015 · American Heart Journal
Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis
Jingzhen Li, Lijuan Wang, Jinzhu Hu, Gaosi Xu · 2015 · Nutrition Metabolism and Cardiovascular Diseases
Can We Predict Stroke in Atrial Fibrillation?
Gregory Y.H. Lip · 2012 · Clinical Cardiology
Screening for undiagnosed atrial fibrillation in the community
Quinn, F. Russell, Gladstone, David · 2014 · Current Opinion in Cardiology